Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
---|
03/11/2009 | CN101381356A Preparation method of simvastatin |
03/11/2009 | CN101381345A Tetrahydroquinoline derivatives and a process for preparing the same |
03/11/2009 | CN101380476A Albumin-binding derivatives of therapeutic peptides |
03/11/2009 | CN101380462A Obtaining method of novel insulin oil-phase solution and preparation technique thereof |
03/11/2009 | CN101380418A Tangniaole capsule for treating diabetes and preparation method thereof |
03/11/2009 | CN101380415A Medicament for preventing and treating diabetes |
03/11/2009 | CN101380410A Medicine for treating hyperactivity of fire due to yin deficiency and preparation method of the formulation thereof |
03/11/2009 | CN101380398A Composition for prevention and treatment of cardio-cerebrolvascular disease |
03/11/2009 | CN101380390A Preparation method of Pu-Er ripe tea standard extract PRC-001 and preparation method and use thereof |
03/11/2009 | CN101380378A Medicine composition for preventing the birth defect and improving the memory |
03/11/2009 | CN101380377A Medicine composition for preventing the birth defect and improving the memory |
03/11/2009 | CN101380364A Herbal product to be administered to diabetic individuals and the production method thereof |
03/11/2009 | CN101380363A Medicine composition for preventing the birth defect and improving the memory |
03/11/2009 | CN101380358A Disinsection composition with synergistic action |
03/11/2009 | CN101380353A Pharmaceutical composite for preventing and curing 2-type diabetes and preparation method thereof |
03/11/2009 | CN101380352A Medicine composition for preventing the birth defect and improving the memory |
03/11/2009 | CN101380351A Medicine composition for preventing the birth defect and improving the memory |
03/11/2009 | CN101380343A Extraction from mixture of angelica and ligusticum wallichii rhizome and extraction method |
03/11/2009 | CN101380339A Extraction method of Heidouba effective constituent |
03/11/2009 | CN101380334A Method for reducing blood-sugar using blood-sugar bacterial of compound micro-ecological preparation |
03/11/2009 | CN101380331A New function of gastrodine /gastrodia tuber micro-powder for lowering lipid |
03/11/2009 | CN101380324A Pharmaceutical composition containing lacidipine and atorvastatin and preparation method and use thereof |
03/11/2009 | CN101380319A Inhibitors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma |
03/11/2009 | CN101380311A Diabecron sustained-release tablet and preparation method thereof |
03/11/2009 | CN101380290A Novel controlled release-niacin formulation |
03/11/2009 | CN101380129A Beverage for reducing weight, protect and strengthen health and production technique thereof |
03/11/2009 | CN101380112A Medicine composition for preventing the birth defect and improving the memory |
03/11/2009 | CN101380104A Medicated diet therapeutics for treating calcium loss |
03/11/2009 | CN101380099A Food capable of reducing blood pressure |
03/11/2009 | CN101380095A Composite effervescent formulation containing peony extract |
03/11/2009 | CN101380070A Apples honey sauce with weight reduction function |
03/11/2009 | CN101380049A Black tea extract rich in statins and preparation technique and use thereof |
03/11/2009 | CN100467601C PIM-3 kinase as a target for type 2 diabetes mellitus |
03/11/2009 | CN100467596C Insulin-expressing human islet cell lines capable of reversibly proliferating and use thereof |
03/11/2009 | CN100467583C Beta glucan-containing fat and oil compositions and novel microorganism capable of producing beta-glucan |
03/11/2009 | CN100467469C A2b adenosine receptor antagonists |
03/11/2009 | CN100467458C Indanyl-piperazine derivatives, process for their preparation and pharmaceutical compositions containing them |
03/11/2009 | CN100467456C Alpha-piperazine substituted phenyl-propionic acid derivatives as hPPAR alpha and hPPAR gamma agonist |
03/11/2009 | CN100467450C Anthranilic acid amides and pharmaceutical use thereof |
03/11/2009 | CN100467448C Acid-group-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use |
03/11/2009 | CN100467447C Thioamide compound or its salt and cytokine production inhibitor containing the same |
03/11/2009 | CN100467443C 6-(aryl-amido or aryl-amidomethyl)-naphthalen-2-yloxy-acidic derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1) |
03/11/2009 | CN100467047C Traditional Chinese medicine for preventing, treating and reverting diabetes and its complications |
03/11/2009 | CN100467046C Sugar decreasing composition of fenugreek seed |
03/11/2009 | CN100467038C Biological and pharmacological effects and preparation process of liver protecting preparation containing vitamins |
03/11/2009 | CN100467031C Medical use of burdock total lignanoid |
03/11/2009 | CN100467012C Separately packed structural fatty milk, aminoacid and glucose injection composition and the preparation process |
03/11/2009 | CN100466924C Corrective clothes with liner |
03/11/2009 | CN100466919C Flour made of broom corn millet and its production method |
03/10/2009 | US7501525 Derivatives of benzimidazole and their use as medicaments |
03/10/2009 | US7501524 Melacocortin receptors; analgesics; antiinflammatory agents; eating disorders; psychological disorders; anxiolytic agents; antidepressants; anticancer agents; aids; antiarthritic agents |
03/10/2009 | US7501516 3-Cyanoquinolines 4-substituted by a methylenedioxyphenyl group that is attached by a methylene, oxy, thio, sulfinyl, sulfonyl or amino group; antitumor agents |
03/10/2009 | US7501511 Process for resolving aimines that are useful for the treatment of disorders associated with insulin resistance syndrome |
03/10/2009 | US7501450 Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms |
03/10/2009 | US7501441 for treating uterine fibroid disease; [2-(4-hydroxyphenyl)-6-hydroxynaphthalen-1-yl][4-(2-(1-piperidinyl)ethoxy)phenyl]methane; therapy for post manupausal women |
03/10/2009 | US7501437 2-[(2-Isopropylsulfanyl-3-oxo-spiro[3.5]non-1-en-1-yl)amino]-3-[4-([2,7]naphthyridin-1-ylamino)phenyl]propanoic acid; compounds can inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immuno or inflammatory disorders |
03/10/2009 | US7501431 Physiologically active substances PF1270A, B and C substances |
03/10/2009 | US7501426 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions |
03/10/2009 | US7501418 e.g. 3-[4-(2-Methyl-3-phenyl-allyl)-piperazin-1-ylmethyl]-3a,4-dihydro-3H-2,5-dioxa-1,7-diaza-dicyclopenta[a,g]naphthalene; serotonine (5-HT) reuptake inhibitor, alpha 2-adrenoceptor antagonist; antidepressant, anxiolytic agent; Parkinson's disease, eating disorders, psychosis, obesity |
03/10/2009 | US7501417 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
03/10/2009 | US7501407 Amide substituted pyrimidine compound; antiarthritic agents; antiischemic agents; antidiabetic agents; inflammatory bowel disease; antiproliferative agents; antiallergens |
03/10/2009 | US7501405 Combination therapy using an 11β-hydroxysteroid dehydrogenase type 1 inhibitor and an antihypertensive agent for the treatment of metabolic syndrome and related diseases and disorders |
03/10/2009 | US7501403 Bile acid or bile salt fatty acid conjugates |
03/10/2009 | US7501399 Immunoeffector compounds |
03/10/2009 | US7501265 Method for producing and cleaving a fusion proteins with an n-terminal chymosin pro-peptide |
03/10/2009 | US7501124 Administering allogenic or xenogeneric cell; complexing with antigen |
03/10/2009 | US7501116 Placental alkaline phosphatase to control diabetes |
03/10/2009 | US7501115 Providing a tissue removal system; removing adipose tissue from a patient using the tissue removal system, the adipose tissue having a concentration of stem cells; processing at least a part of the adipose tissue to obtain a concentration |
03/10/2009 | CA2415068C Oral compositions comprising antimicrobial agents |
03/10/2009 | CA2394602C New modulators of dopamine neurotransmission |
03/10/2009 | CA2377233C Intermediates for the synthesis of benzimidazole compounds and process for the preparation thereof |
03/10/2009 | CA2368418C 1-arenesulfonyl-2-aryl-pyrrolidine and piperidine derivatives for the treatment of cns disorders |
03/10/2009 | CA2342210C Thiazoline acid derivatives |
03/10/2009 | CA2336853C Phenoxyacetic acid derivatives and medicinal compositions containing the same |
03/05/2009 | WO2009029214A1 Isoquinolone derivatives as phosphodiesterase 10 inhibitors |
03/05/2009 | WO2009028989A2 Overweight treatment method |
03/05/2009 | WO2009028649A1 Method for reduction in volume of solid preparation having high amino acid content |
03/05/2009 | WO2009028248A1 Cyclic heptapeptide and use of the same |
03/05/2009 | WO2009027956A2 Syndrome x composition and method of lowering blood pressure and glycemic index |
03/05/2009 | WO2009027954A1 Appetite suppressant composition and method of appetite suppression |
03/05/2009 | WO2009027753A1 Composition and method inhibiting inflammation |
03/05/2009 | WO2009027276A1 Process for the preparation of pyrido [2, 1-a] isoquinoline derivatives and polymorphic froms thereof |
03/05/2009 | WO2009027264A1 Benzimidazole derivatives used as fxr agonists |
03/05/2009 | WO2009027106A2 Non-invasive in vivo imaging and methods for treating type i diabetes |
03/05/2009 | WO2009026701A1 Sirtuin inhibitors |
03/05/2009 | WO2009026658A1 Ppar agonists |
03/05/2009 | WO2009026657A1 Flavonoid ppar agonists |
03/05/2009 | WO2009026614A1 Hypoglycaemic tripeptide and methods of use thereof |
03/05/2009 | WO2009014471A3 Method for producing mechanically activated amorphous and amorphocrystalline compounds of gluconic acid calcium salt |
03/05/2009 | WO2009010416A3 Inhibitors of 11b-hydroxysteroid dehydrogenase |
03/05/2009 | WO2008148868A8 Piperidine/piperazine derivatives |
03/05/2009 | WO2008148849A8 Piperidine/piperazine derivatives |
03/05/2009 | WO2008062276A3 Acetylene derivatives as stearoyl coa desaturase inhibitors |
03/05/2009 | WO2008061902A3 Targeting of l-3-hydroxyacyl-coenzyme a dehydrogenase, short chain (hadhsc) in disorders of glucose homeostasis |
03/05/2009 | WO2008024374A3 Inhibitors of pancreatic phospholipase a2 for altering cholesterol and fat uptake |
03/05/2009 | WO2007126365A8 Further medical uses of antisecretory protein |
03/05/2009 | WO2006134340A9 Oxyntomodulin analogues and their effects on feeding behaviour |
03/05/2009 | US20090062401 Decaline-derived compounds as pharmaceutically active agents |
03/05/2009 | US20090062396 Novel Haloalkoxy-Substituted Salicylic Anilides |
03/05/2009 | US20090062358 Peroxisome proliferator activated receptor alpha agonists |